Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges
Randomised Controlled Trial Investigating the Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges in Smokers
1 other identifier
observational
100
1 country
1
Brief Summary
The study's major aim is to investigate the ability of a commercial Electronic Nicotine Delivery Device (E-Cigarette) to induce long-term smoking reduction/abstinence in smokers unwilling to quit. Secondary aims are to investigate changes in withdrawal symptoms and cravings and to examine whether concomitant use of the E-Cigarette and smoking is safe. The study will monitor smoking reduction/abstinence effects, changes in withdrawal symptoms, and adverse events of a currently marketed device in Italy ("Categoria" electronic cigarette - "NO nicotine" cartridges). The primary hypothesis is that the E-Cigarette is a safe device that allows smoking reduction or abstinence in smokers possibly by suppressing withdrawal symptoms and cravings independently from nicotine delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 2, 2010
CompletedFirst Posted
Study publicly available on registry
September 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedJanuary 8, 2013
January 1, 2013
2 years
September 2, 2010
January 7, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Sustained 50% reduction in the number of cigarettes smoked per day at week-12 from baseline
50% reduction in the number of cigarettes smoked per day documented at each study visit (week-2, -4, -6, -8, -10, and -12)
week-12
Sustained smoking abstinence at week-12
Sustained smoking abstinence at week-12, defined as complete abstinence from tobacco smoking (not even a puff) for the 14 days period prior to week-12 study visit; exhaled CO levels will be measured to objectively verify smoking status.
week 12
Secondary Outcomes (7)
Sustained 80% reduction in the number of cigarettes smoked per day at week-12 from baseline
week-12
Sustained smoking abstinence at week-24
week 24
Sustained 50% reduction in the number of cigarettes smoked per day at week-24 from baseline
week-24
Sustained 80% reduction in the number of cigarettes smoked per day at week-24 from baseline
week-24
Withdrawal suppression (by MNWS)
24 weeks
- +2 more secondary outcomes
Study Arms (1)
NO NICOTINE
Well characterized group of 100 regular smokers experimenting the E-Cigarette without nicotine cartridges (NO nicotine group).
Eligibility Criteria
Regular smokers from Catania in Italy recruited following the placement of an advertisement in a local newspaper.
You may qualify if:
- healthy smokers unwilling to quit, between 18 and 60 years of age. They should report a cigarette intake of ≥ 15 cig/day for at least 5 years. At screening they must provide a CO level of ≥ 15 ppm and an FTND ≥ 5.
You may not qualify if:
- alcohol and illicit drug use, breastfeeding, or pregnancy. Individuals who report current attempts to quit smoking and previous experience with electronic cigarettes will be also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universita degli Studi di Catanialead
- Lega Italiana Anti Fumocollaborator
- Arbi Group Srlcollaborator
Study Sites (1)
Dipartimento di Medicina Interna e Specialistica; Centro per la Prevenzione e Cura del Tabagismo (CPCT)
Catania, 95124, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Riccardo Polosa, MD, PhD
Università di Catania
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Internal Medicine
Study Record Dates
First Submitted
September 2, 2010
First Posted
September 3, 2010
Study Start
April 1, 2010
Primary Completion
April 1, 2012
Study Completion
April 1, 2012
Last Updated
January 8, 2013
Record last verified: 2013-01